ProShare Advisors’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-1,401
| Closed | -$77K | – | 1772 |
|
|
2018
Q3 | $77K | Sell |
1,401
-24
| -2% | -$1.32K | ﹤0.01% | 1700 |
|
|
2018
Q2 | $102K | Sell |
1,425
-97
| -6% | -$6.94K | ﹤0.01% | 1707 |
|
|
2018
Q1 | $93K | Sell |
1,522
-241
| -14% | -$14.7K | ﹤0.01% | 1641 |
|
|
2017
Q4 | $222K | Buy |
+1,763
| New | +$222K | ﹤0.01% | 1590 |
|
|
2016
Q4 | – | Sell |
-1,337
| Closed | -$102K | – | 1764 |
|
|
2016
Q3 | $102K | Sell |
1,337
-248
| -16% | -$18.9K | ﹤0.01% | 1416 |
|
|
2016
Q2 | $136K | Buy |
1,585
+19
| +1% | +$1.63K | ﹤0.01% | 1491 |
|
|
2016
Q1 | $145K | Sell |
1,566
-166
| -10% | -$15.4K | ﹤0.01% | 1474 |
|
|
2015
Q4 | $347K | Buy |
1,732
+171
| +11% | +$34.3K | ﹤0.01% | 1225 |
|
|
2015
Q3 | $233K | Sell |
1,561
-110
| -7% | -$16.4K | ﹤0.01% | 1243 |
|
|
2015
Q2 | $1.59M | Buy |
1,671
+184
| +12% | +$175K | 0.02% | 586 |
|
|
2015
Q1 | $1.09M | Buy |
1,487
+192
| +15% | +$141K | 0.01% | 805 |
|
|
2014
Q4 | $1.03M | Buy |
+1,295
| New | +$1.03M | 0.01% | 835 |
|
|
2014
Q3 | – | Sell |
-537
| Closed | -$145K | – | 2401 |
|
|
2014
Q2 | $145K | Sell |
537
-173
| -24% | -$46.7K | ﹤0.01% | 2276 |
|
|
2014
Q1 | $155K | Buy |
+710
| New | +$155K | ﹤0.01% | 2603 |
|